These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 25636412)

  • 21. Risk factors for encapsulating peritoneal sclerosis in long-term peritoneal dialysis: a retrospective observational study.
    Nakao M; Yokoyama K; Yamamoto I; Matsuo N; Tanno Y; Ohkido I; Hayakawa H; Ikeda M; Yamamoto H; Hosoya T
    Ther Apher Dial; 2014 Feb; 18(1):68-73. PubMed ID: 24499086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Encapsulating peritoneal sclerosis in children on chronic PD: a survey from the European Paediatric Dialysis Working Group.
    Shroff R; Stefanidis CJ; Askiti V; Edefonti A; Testa S; Ekim M; Kavaz A; Ariceta G; Bakkaloglu S; Fischbach M; Klaus G; Zurowska A; Holtta T; Jankauskiene A; Vondrak K; Vande Walle J; Schmitt CP; Watson AR;
    Nephrol Dial Transplant; 2013 Jul; 28(7):1908-14. PubMed ID: 23348882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphologic characteristics of macroscopic peritoneal finding in patients with peritoneal dialysis.
    Hamada C; Nakamoto H; Suzuki Y
    J Artif Organs; 2018 Mar; 21(1):102-109. PubMed ID: 28988370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Encapsulating peritoneal sclerosis].
    Torres R; Ebner P; Sanhueza ME; Alvo M; Segovia E; Segura P
    Rev Med Chil; 2017 Jan; 145(1):41-48. PubMed ID: 28393968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Encapsulating Peritoneal Sclerosis in Peritoneal Dialysis Patients After Kidney Transplantation.
    Ayar Y; Ersoy A; Ocakoglu G; Gullulu E; Kagızmanlı H; Yıldız A; Oruc A; Yavuz M; Gullulu M; Dilek K
    Transplant Proc; 2018; 50(1):160-164. PubMed ID: 29407302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early Detection of Imminent Encapsulating Peritoneal Sclerosis: Free Water Transport, Selected Effluent Proteins, or Both?
    Barreto DL; Sampimon DE; Struijk DG; Krediet RT
    Perit Dial Int; 2019; 39(1):83-89. PubMed ID: 30478138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors of severe peritoneal sclerosis in chronic peritoneal dialysis patients.
    Alatab S; Najafi I; Pourmand G; Hosseini M; Shekarchian S
    Ren Fail; 2017 Nov; 39(1):32-39. PubMed ID: 27774831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The time course of peritoneal transport parameters in peritoneal dialysis patients who develop encapsulating peritoneal sclerosis.
    Sampimon DE; Coester AM; Struijk DG; Krediet RT
    Nephrol Dial Transplant; 2011 Jan; 26(1):291-8. PubMed ID: 20566569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis?].
    Bertoli SV; Musetti C
    G Ital Nefrol; 2010; 27(5):464-8. PubMed ID: 20922677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Encapsulating Peritoneal Sclerosis.
    Alston H; Fan S; Nakayama M
    Semin Nephrol; 2017 Jan; 37(1):93-102. PubMed ID: 28153198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan.
    Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E
    Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-transport membrane is a risk factor for encapsulating peritoneal sclerosis developing after long-term continuous ambulatory peritoneal dialysis treatment.
    Yamamoto R; Nakayama M; Hasegawa T; Miwako N; Yamamoto H; Yokoyami K; Ikeda M; Kato N; Hayakawa H; Takahashi H; Otsuka Y; Kawaguchi Y; Hosoya T
    Adv Perit Dial; 2002; 18():131-4. PubMed ID: 12402604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histomorphological and functional changes of the peritoneal membrane during long-term peritoneal dialysis.
    Fusshoeller A
    Pediatr Nephrol; 2008 Jan; 23(1):19-25. PubMed ID: 17638023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Encapsulating peritoneal sclerosis].
    Ryckelynck JP; Béchade C; Bouvier N; Ficheux M; Hurault de Ligny B; Lobbedez T
    Nephrol Ther; 2017 Jun; 13(4):211-219. PubMed ID: 28576435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of gadolinium deposits in the peritoneal membrane of patients with encapsulating peritoneal sclerosis.
    Goffin E; Schroeder JA; Weingart C; Decleire PY; Cosyns JP
    Nephrol Dial Transplant; 2010 Apr; 25(4):1334-9. PubMed ID: 20007759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasculopathy plays an important role during the development and relapse of encapsulating peritoneal sclerosis with conventional peritoneal dialysis solutions.
    Tawada M; Ito Y; Banshodani M; Yamashita M; Shintaku S; Sun T; Suzuki Y; Kinashi H; Kubo Y; Ando M; Yamaguchi M; Katsuno T; Mizuno M; Kawanishi H
    Nephrol Dial Transplant; 2021 Jul; 36(8):1519-1526. PubMed ID: 32437531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Encapsulating peritoneal sclerosis in an Italian center: thirty year experience.
    Vizzardi V; Sandrini M; Zecchini S; Ravera S; Manili L; Cancarini G
    J Nephrol; 2016 Apr; 29(2):259-267. PubMed ID: 26521254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for developing encapsulating peritoneal sclerosis in the icodextrin era of peritoneal dialysis prescription.
    Habib AM; Preston E; Davenport A
    Nephrol Dial Transplant; 2010 May; 25(5):1633-8. PubMed ID: 20037174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver cirrhosis with encapsulating peritoneal sclerosis after 4 years of peritoneal dialysis: A case report.
    Watanabe-Kusunoki K; Kusunoki Y; Goto J; Kukita K
    Medicine (Baltimore); 2021 Dec; 100(51):e28350. PubMed ID: 34941145
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for encapsulating peritoneal sclerosis: Analysis of a 36-year experience in a University Hospital.
    Nakao M; Yamamoto I; Maruyama Y; Morishita M; Nakashima A; Matsuo N; Tanno Y; Ohkido I; Ikeda M; Yamamoto H; Yokoyama K; Yokoo T
    Nephrology (Carlton); 2017 Nov; 22(11):907-912. PubMed ID: 27556577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.